| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronavirus Infections | 6 | 2020 | 334 | 2.340 |
Why?
|
| Pneumonia, Viral | 5 | 2020 | 346 | 1.570 |
Why?
|
| Disease Models, Animal | 28 | 2019 | 2551 | 1.460 |
Why?
|
| West Nile Fever | 10 | 2008 | 22 | 1.410 |
Why?
|
| Mesocricetus | 18 | 2008 | 103 | 1.260 |
Why?
|
| Coronavirus | 2 | 2020 | 20 | 1.260 |
Why?
|
| Adenocarcinoma | 10 | 2020 | 1215 | 1.200 |
Why?
|
| Phlebovirus | 5 | 2008 | 5 | 1.200 |
Why?
|
| West Nile virus | 10 | 2008 | 17 | 1.190 |
Why?
|
| Liver | 22 | 2020 | 1238 | 1.190 |
Why?
|
| Lung | 10 | 2021 | 1382 | 1.010 |
Why?
|
| Stomach Neoplasms | 7 | 2020 | 310 | 0.940 |
Why?
|
| Immunohistochemistry | 25 | 2020 | 1829 | 0.910 |
Why?
|
| Biomarkers, Tumor | 11 | 2020 | 1665 | 0.900 |
Why?
|
| Lung Neoplasms | 4 | 2021 | 2463 | 0.890 |
Why?
|
| Hepatocytes | 7 | 2018 | 132 | 0.870 |
Why?
|
| Pandemics | 5 | 2020 | 880 | 0.840 |
Why?
|
| Cricetinae | 25 | 2013 | 544 | 0.740 |
Why?
|
| Yellow Fever | 6 | 2006 | 7 | 0.730 |
Why?
|
| Schistosomiasis mansoni | 1 | 2021 | 9 | 0.690 |
Why?
|
| Pancreatic Neoplasms | 4 | 2016 | 725 | 0.690 |
Why?
|
| Crohn Disease | 2 | 2021 | 806 | 0.680 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 35 | 0.670 |
Why?
|
| Intestines | 2 | 2021 | 431 | 0.660 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2020 | 4 | 0.650 |
Why?
|
| Liver Cirrhosis | 7 | 2018 | 276 | 0.640 |
Why?
|
| Pancreatitis | 5 | 2013 | 94 | 0.600 |
Why?
|
| Chiroptera | 1 | 2020 | 56 | 0.590 |
Why?
|
| Aged | 31 | 2021 | 20964 | 0.580 |
Why?
|
| Sciuridae | 4 | 2007 | 18 | 0.570 |
Why?
|
| Liver Diseases | 2 | 2020 | 249 | 0.570 |
Why?
|
| Female | 70 | 2021 | 50063 | 0.560 |
Why?
|
| Pneumonia | 1 | 2020 | 197 | 0.560 |
Why?
|
| Humans | 81 | 2021 | 96127 | 0.550 |
Why?
|
| Esophageal Neoplasms | 6 | 2020 | 346 | 0.550 |
Why?
|
| Betacoronavirus | 5 | 2020 | 284 | 0.540 |
Why?
|
| Neprilysin | 2 | 2012 | 41 | 0.540 |
Why?
|
| Flavivirus Infections | 3 | 2013 | 5 | 0.530 |
Why?
|
| Duodenal Neoplasms | 2 | 2016 | 21 | 0.530 |
Why?
|
| Hepatitis C, Chronic | 5 | 2014 | 96 | 0.530 |
Why?
|
| Monkeypox virus | 3 | 2007 | 7 | 0.520 |
Why?
|
| Antibodies, Viral | 12 | 2008 | 348 | 0.510 |
Why?
|
| Amino Acid Substitution | 4 | 2008 | 336 | 0.510 |
Why?
|
| Myocardium | 1 | 2020 | 596 | 0.510 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 17 | 0.490 |
Why?
|
| Male | 53 | 2021 | 45870 | 0.490 |
Why?
|
| Gastric Mucosa | 3 | 2013 | 70 | 0.480 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2014 | 133 | 0.470 |
Why?
|
| Jejunal Neoplasms | 2 | 2013 | 9 | 0.470 |
Why?
|
| Bile Duct Neoplasms | 3 | 2012 | 91 | 0.460 |
Why?
|
| Yellow fever virus | 6 | 2005 | 7 | 0.460 |
Why?
|
| Middle Aged | 38 | 2021 | 28363 | 0.450 |
Why?
|
| Aged, 80 and over | 14 | 2020 | 7232 | 0.450 |
Why?
|
| Bunyaviridae Infections | 2 | 2005 | 2 | 0.450 |
Why?
|
| Animals | 52 | 2021 | 28945 | 0.440 |
Why?
|
| Intestinal Perforation | 4 | 2007 | 39 | 0.430 |
Why?
|
| Ileal Neoplasms | 1 | 2013 | 9 | 0.410 |
Why?
|
| Endoscopic Mucosal Resection | 3 | 2020 | 28 | 0.410 |
Why?
|
| Colorectal Neoplasms | 6 | 2019 | 1069 | 0.400 |
Why?
|
| Adult | 33 | 2021 | 28718 | 0.400 |
Why?
|
| Doxycycline | 1 | 2013 | 37 | 0.380 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2013 | 62 | 0.380 |
Why?
|
| Antigens, Viral | 9 | 2013 | 135 | 0.380 |
Why?
|
| Colonoscopy | 4 | 2007 | 304 | 0.370 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2012 | 12 | 0.370 |
Why?
|
| Apoptosis | 4 | 2008 | 1763 | 0.360 |
Why?
|
| Biopsy | 7 | 2021 | 1220 | 0.350 |
Why?
|
| Thogotovirus | 2 | 2008 | 2 | 0.350 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 257 | 0.350 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2018 | 426 | 0.340 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2008 | 57 | 0.340 |
Why?
|
| Flavivirus | 3 | 2013 | 5 | 0.340 |
Why?
|
| Axilla | 3 | 2019 | 110 | 0.330 |
Why?
|
| Liver Neoplasms | 6 | 2018 | 793 | 0.320 |
Why?
|
| Rift Valley Fever | 2 | 2007 | 2 | 0.320 |
Why?
|
| China | 3 | 2020 | 264 | 0.320 |
Why?
|
| Contractile Proteins | 2 | 2020 | 57 | 0.310 |
Why?
|
| Surgical Instruments | 3 | 2007 | 63 | 0.310 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2020 | 190 | 0.300 |
Why?
|
| Liver Function Tests | 6 | 2014 | 94 | 0.300 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2020 | 898 | 0.290 |
Why?
|
| Viremia | 10 | 2008 | 53 | 0.290 |
Why?
|
| Genome, Viral | 3 | 2007 | 80 | 0.290 |
Why?
|
| Granuloma | 1 | 2008 | 65 | 0.290 |
Why?
|
| RNA, Viral | 8 | 2009 | 311 | 0.290 |
Why?
|
| Hantavirus Infections | 1 | 2008 | 2 | 0.280 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 1807 | 0.280 |
Why?
|
| Kidney | 5 | 2013 | 1156 | 0.270 |
Why?
|
| Rift Valley fever virus | 1 | 2007 | 1 | 0.270 |
Why?
|
| Gene Amplification | 3 | 2018 | 143 | 0.270 |
Why?
|
| Influenza A virus | 1 | 2008 | 177 | 0.260 |
Why?
|
| Intestinal Mucosa | 3 | 2006 | 825 | 0.260 |
Why?
|
| Chronic Disease | 5 | 2021 | 983 | 0.260 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 847 | 0.260 |
Why?
|
| Young Adult | 7 | 2021 | 7025 | 0.260 |
Why?
|
| Virulence | 5 | 2008 | 279 | 0.260 |
Why?
|
| Colitis, Microscopic | 1 | 2006 | 6 | 0.250 |
Why?
|
| Diagnosis, Differential | 4 | 2021 | 1619 | 0.250 |
Why?
|
| Antigens, CD1 | 1 | 2006 | 37 | 0.250 |
Why?
|
| Aspartate Aminotransferases | 4 | 2014 | 75 | 0.250 |
Why?
|
| Colon | 6 | 2017 | 541 | 0.240 |
Why?
|
| Colonic Diseases | 1 | 2006 | 61 | 0.240 |
Why?
|
| Spleen | 10 | 2007 | 439 | 0.240 |
Why?
|
| Arenaviruses, New World | 2 | 2006 | 2 | 0.240 |
Why?
|
| Viral Nonstructural Proteins | 4 | 2009 | 38 | 0.230 |
Why?
|
| Hepacivirus | 4 | 2009 | 137 | 0.230 |
Why?
|
| Lymph Nodes | 2 | 2019 | 565 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2019 | 1469 | 0.230 |
Why?
|
| Mucins | 2 | 2016 | 40 | 0.230 |
Why?
|
| Colonic Neoplasms | 2 | 2019 | 589 | 0.220 |
Why?
|
| Influenza, Human | 1 | 2008 | 370 | 0.220 |
Why?
|
| Phylogeny | 3 | 2007 | 1275 | 0.220 |
Why?
|
| Pain | 5 | 2005 | 426 | 0.220 |
Why?
|
| Lymphocytes | 1 | 2006 | 489 | 0.210 |
Why?
|
| Retrospective Studies | 9 | 2021 | 10286 | 0.210 |
Why?
|
| Cytokines | 1 | 2008 | 872 | 0.210 |
Why?
|
| Bunyaviridae | 1 | 2003 | 1 | 0.210 |
Why?
|
| Barrett Esophagus | 2 | 2014 | 94 | 0.200 |
Why?
|
| Colitis | 2 | 2019 | 262 | 0.200 |
Why?
|
| Disease Outbreaks | 2 | 2020 | 157 | 0.200 |
Why?
|
| Leukocyte Count | 2 | 2020 | 228 | 0.200 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 1020 | 0.200 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2019 | 647 | 0.200 |
Why?
|
| Phlebotomus Fever | 1 | 2003 | 1 | 0.200 |
Why?
|
| Thigh | 1 | 2003 | 41 | 0.200 |
Why?
|
| Abdominal Neoplasms | 1 | 2003 | 40 | 0.200 |
Why?
|
| Sarcoma, Ewing | 1 | 2003 | 43 | 0.190 |
Why?
|
| Viral Vaccines | 3 | 2008 | 48 | 0.190 |
Why?
|
| Adolescent | 7 | 2021 | 9896 | 0.190 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2011 | 68 | 0.190 |
Why?
|
| Esophagoscopy | 3 | 2014 | 91 | 0.190 |
Why?
|
| Femur | 1 | 2003 | 108 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 2781 | 0.190 |
Why?
|
| Carcinoma, Small Cell | 1 | 2003 | 137 | 0.190 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2021 | 161 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2014 | 201 | 0.180 |
Why?
|
| Viral Proteins | 1 | 2003 | 289 | 0.180 |
Why?
|
| Molecular Sequence Data | 4 | 2007 | 3041 | 0.170 |
Why?
|
| Hemorrhagic Fever, American | 1 | 2001 | 1 | 0.170 |
Why?
|
| Parasite Egg Count | 1 | 2021 | 7 | 0.170 |
Why?
|
| Schistosoma mansoni | 1 | 2021 | 17 | 0.170 |
Why?
|
| Gastritis, Hypertrophic | 1 | 2001 | 4 | 0.170 |
Why?
|
| Rhinoscleroma | 1 | 2001 | 2 | 0.170 |
Why?
|
| Lymph Node Excision | 2 | 2019 | 235 | 0.170 |
Why?
|
| Gallbladder Neoplasms | 1 | 2020 | 23 | 0.170 |
Why?
|
| Lifting | 1 | 2020 | 12 | 0.160 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 320 | 0.160 |
Why?
|
| STAT6 Transcription Factor | 1 | 2020 | 29 | 0.160 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 15 | 0.160 |
Why?
|
| Hypertrophy | 1 | 2020 | 68 | 0.160 |
Why?
|
| Lymphopenia | 1 | 2020 | 32 | 0.160 |
Why?
|
| Carcinogenesis | 2 | 2019 | 237 | 0.160 |
Why?
|
| Patient Care Management | 1 | 2020 | 30 | 0.160 |
Why?
|
| Treatment Outcome | 13 | 2020 | 9173 | 0.160 |
Why?
|
| Autopsy | 1 | 2020 | 129 | 0.160 |
Why?
|
| Respiratory System | 1 | 2020 | 121 | 0.160 |
Why?
|
| Cytomegalovirus Infections | 1 | 2001 | 155 | 0.160 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 79 | 0.150 |
Why?
|
| Sparganosis | 1 | 2019 | 1 | 0.150 |
Why?
|
| Stromal Cells | 1 | 2020 | 154 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 908 | 0.150 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 134 | 0.150 |
Why?
|
| Rodent Diseases | 2 | 2013 | 35 | 0.150 |
Why?
|
| Lymphatic System | 1 | 2019 | 55 | 0.150 |
Why?
|
| Organ Sparing Treatments | 1 | 2019 | 47 | 0.150 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 17 | 0.150 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 109 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 299 | 0.150 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 151 | 0.150 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 59 | 0.150 |
Why?
|
| Arm | 1 | 2019 | 100 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 132 | 0.150 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2019 | 86 | 0.150 |
Why?
|
| Fibrosis | 1 | 2020 | 246 | 0.150 |
Why?
|
| Alphavirus Infections | 2 | 2008 | 4 | 0.150 |
Why?
|
| Glucuronosyltransferase | 1 | 2020 | 186 | 0.150 |
Why?
|
| Chikungunya virus | 2 | 2008 | 4 | 0.150 |
Why?
|
| Observer Variation | 2 | 2020 | 626 | 0.150 |
Why?
|
| Base Sequence | 4 | 2007 | 2344 | 0.140 |
Why?
|
| Testicular Neoplasms | 1 | 2000 | 123 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 465 | 0.140 |
Why?
|
| Lymphoma, T-Cell | 1 | 2019 | 61 | 0.140 |
Why?
|
| Adenoma | 2 | 2016 | 260 | 0.140 |
Why?
|
| Endoscopy | 3 | 2020 | 374 | 0.140 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 226 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 154 | 0.140 |
Why?
|
| Radiography | 1 | 2020 | 826 | 0.140 |
Why?
|
| Endosonography | 3 | 2009 | 101 | 0.140 |
Why?
|
| Lymphedema | 1 | 2019 | 84 | 0.140 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2018 | 25 | 0.140 |
Why?
|
| Pancreas | 6 | 2006 | 264 | 0.140 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2011 | 70 | 0.140 |
Why?
|
| Anus Neoplasms | 1 | 2018 | 38 | 0.140 |
Why?
|
| Dissection | 1 | 2017 | 45 | 0.130 |
Why?
|
| Cetuximab | 1 | 2018 | 119 | 0.130 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 2092 | 0.130 |
Why?
|
| Virus Replication | 3 | 2008 | 326 | 0.130 |
Why?
|
| Breast | 1 | 2019 | 297 | 0.130 |
Why?
|
| DNA Fragmentation | 2 | 2008 | 65 | 0.130 |
Why?
|
| Gene Expression | 3 | 2008 | 1322 | 0.130 |
Why?
|
| Colonoscopes | 2 | 2007 | 13 | 0.130 |
Why?
|
| Camptothecin | 1 | 2018 | 204 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2001 | 124 | 0.130 |
Why?
|
| Sex Factors | 1 | 2020 | 1133 | 0.130 |
Why?
|
| Caspases | 2 | 2008 | 156 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 180 | 0.130 |
Why?
|
| Urine | 2 | 2008 | 96 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2020 | 447 | 0.130 |
Why?
|
| Platelet Count | 2 | 2007 | 97 | 0.130 |
Why?
|
| Nociceptors | 3 | 2005 | 30 | 0.130 |
Why?
|
| Mesothelioma | 1 | 2000 | 333 | 0.130 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 1034 | 0.130 |
Why?
|
| Cholangiocarcinoma | 2 | 2011 | 80 | 0.130 |
Why?
|
| CDX2 Transcription Factor | 1 | 2016 | 7 | 0.120 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 547 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1981 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 466 | 0.120 |
Why?
|
| Vero Cells | 5 | 2008 | 106 | 0.120 |
Why?
|
| Suture Techniques | 2 | 2007 | 143 | 0.120 |
Why?
|
| Fatty Liver | 2 | 2010 | 108 | 0.120 |
Why?
|
| Carcinoma | 2 | 2014 | 449 | 0.120 |
Why?
|
| Age Factors | 1 | 2020 | 1963 | 0.120 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 82 | 0.120 |
Why?
|
| Hepatitis C | 2 | 2009 | 185 | 0.120 |
Why?
|
| Abdominal Pain | 3 | 2013 | 145 | 0.110 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 3147 | 0.110 |
Why?
|
| Antibody Formation | 3 | 2006 | 181 | 0.110 |
Why?
|
| Inflammation | 2 | 2020 | 1068 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2020 | 3974 | 0.110 |
Why?
|
| Encephalitis Virus, St. Louis | 2 | 2007 | 2 | 0.110 |
Why?
|
| Narrow Band Imaging | 1 | 2014 | 7 | 0.110 |
Why?
|
| Feasibility Studies | 4 | 2019 | 819 | 0.110 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 2081 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 3 | 2015 | 298 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 366 | 0.110 |
Why?
|
| Swine | 5 | 2007 | 618 | 0.110 |
Why?
|
| Necrosis | 2 | 2013 | 210 | 0.110 |
Why?
|
| Sequence Alignment | 2 | 2007 | 360 | 0.110 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 301 | 0.110 |
Why?
|
| Prospective Studies | 8 | 2019 | 4671 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 286 | 0.110 |
Why?
|
| Child | 3 | 2020 | 7626 | 0.110 |
Why?
|
| Smad4 Protein | 1 | 2013 | 26 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2014 | 131 | 0.100 |
Why?
|
| Keratins | 1 | 2013 | 64 | 0.100 |
Why?
|
| Metaplasia | 1 | 2013 | 39 | 0.100 |
Why?
|
| Keratin-7 | 1 | 2013 | 10 | 0.100 |
Why?
|
| Receptor, ErbB-2 | 1 | 2015 | 280 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 2642 | 0.100 |
Why?
|
| Panax notoginseng | 1 | 2013 | 23 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 206 | 0.100 |
Why?
|
| Esophageal Motility Disorders | 1 | 2013 | 17 | 0.100 |
Why?
|
| Proteomics | 1 | 2015 | 269 | 0.100 |
Why?
|
| Antiviral Agents | 3 | 2007 | 504 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2014 | 156 | 0.100 |
Why?
|
| Mucous Membrane | 1 | 2013 | 85 | 0.100 |
Why?
|
| Hemagglutination Inhibition Tests | 3 | 2007 | 42 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2017 | 451 | 0.100 |
Why?
|
| Esophagitis | 1 | 2013 | 43 | 0.100 |
Why?
|
| Constipation | 1 | 2013 | 69 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2013 | 134 | 0.100 |
Why?
|
| ras Proteins | 1 | 2013 | 134 | 0.100 |
Why?
|
| Capillaries | 1 | 2013 | 86 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 72 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 227 | 0.090 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 2040 | 0.090 |
Why?
|
| Mice | 9 | 2019 | 12562 | 0.090 |
Why?
|
| Bile Duct Diseases | 1 | 2012 | 23 | 0.090 |
Why?
|
| Withholding Treatment | 1 | 2013 | 121 | 0.090 |
Why?
|
| Viral Core Proteins | 2 | 2009 | 28 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2013 | 248 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 481 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 197 | 0.090 |
Why?
|
| Genomics | 1 | 2017 | 855 | 0.090 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2012 | 108 | 0.090 |
Why?
|
| Bile | 1 | 2011 | 61 | 0.090 |
Why?
|
| Biopsy, Needle | 3 | 2019 | 232 | 0.090 |
Why?
|
| Ganglia, Spinal | 4 | 2005 | 76 | 0.090 |
Why?
|
| Remission Induction | 1 | 2013 | 769 | 0.080 |
Why?
|
| Viral Structural Proteins | 2 | 2008 | 17 | 0.080 |
Why?
|
| Arginase | 1 | 2010 | 16 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 684 | 0.080 |
Why?
|
| Hepatitis C Antigens | 1 | 2009 | 1 | 0.080 |
Why?
|
| Wound Healing | 3 | 2007 | 378 | 0.080 |
Why?
|
| Quantum Dots | 1 | 2009 | 20 | 0.080 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2009 | 17 | 0.080 |
Why?
|
| Genes, Viral | 2 | 2008 | 109 | 0.080 |
Why?
|
| Serial Passage | 1 | 2008 | 3 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 1351 | 0.070 |
Why?
|
| Genes, bcl-2 | 1 | 2008 | 15 | 0.070 |
Why?
|
| Leucovorin | 2 | 2020 | 227 | 0.070 |
Why?
|
| Caspase Inhibitors | 1 | 2008 | 32 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 21 | 0.070 |
Why?
|
| DNA Primers | 3 | 2005 | 548 | 0.070 |
Why?
|
| Pancreatic Ducts | 2 | 2006 | 30 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2008 | 56 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2008 | 53 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 2794 | 0.070 |
Why?
|
| Pancreatitis, Chronic | 1 | 2009 | 61 | 0.070 |
Why?
|
| Protein Subunits | 1 | 2008 | 126 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2011 | 1103 | 0.070 |
Why?
|
| ROC Curve | 4 | 2014 | 797 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2020 | 527 | 0.070 |
Why?
|
| Yellow Fever Vaccine | 1 | 2007 | 2 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 1105 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 149 | 0.070 |
Why?
|
| Nucleoproteins | 1 | 2007 | 23 | 0.070 |
Why?
|
| Complement Fixation Tests | 1 | 2007 | 4 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 380 | 0.070 |
Why?
|
| Receptor, PAR-2 | 2 | 2004 | 3 | 0.070 |
Why?
|
| Random Allocation | 3 | 2019 | 327 | 0.070 |
Why?
|
| Animal Diseases | 1 | 2007 | 5 | 0.070 |
Why?
|
| Antigenic Variation | 1 | 2007 | 28 | 0.070 |
Why?
|
| Fluorouracil | 2 | 2020 | 555 | 0.070 |
Why?
|
| Italy | 1 | 2007 | 112 | 0.070 |
Why?
|
| Insulin, Long-Acting | 1 | 2007 | 5 | 0.070 |
Why?
|
| Encephalitis | 1 | 2007 | 101 | 0.070 |
Why?
|
| Death | 1 | 2008 | 97 | 0.070 |
Why?
|
| Encephalitis, St. Louis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 367 | 0.060 |
Why?
|
| Swine Diseases | 1 | 2006 | 15 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 305 | 0.060 |
Why?
|
| Mycophenolic Acid | 1 | 2007 | 86 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 2883 | 0.060 |
Why?
|
| Hepatitis, Chronic | 1 | 2006 | 5 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 90 | 0.060 |
Why?
|
| Arenaviridae Infections | 1 | 2006 | 4 | 0.060 |
Why?
|
| Antigens, CD1d | 1 | 2006 | 32 | 0.060 |
Why?
|
| Peritonitis | 1 | 2006 | 29 | 0.060 |
Why?
|
| Peritoneum | 1 | 2006 | 56 | 0.060 |
Why?
|
| Granuloma, Pyogenic | 1 | 2006 | 4 | 0.060 |
Why?
|
| Benzamides | 1 | 2007 | 248 | 0.060 |
Why?
|
| Intestinal Polyps | 1 | 2006 | 27 | 0.060 |
Why?
|
| Rectal Diseases | 1 | 2006 | 23 | 0.060 |
Why?
|
| Sigmoidoscopy | 1 | 2006 | 38 | 0.060 |
Why?
|
| Mutation | 4 | 2019 | 4374 | 0.060 |
Why?
|
| Fluorescein | 1 | 2005 | 14 | 0.060 |
Why?
|
| Caspase 7 | 1 | 2005 | 15 | 0.060 |
Why?
|
| Annexin A5 | 1 | 2005 | 20 | 0.060 |
Why?
|
| Adrenal Glands | 2 | 2007 | 78 | 0.060 |
Why?
|
| Enteritis | 1 | 2005 | 23 | 0.060 |
Why?
|
| G1 Phase | 1 | 2005 | 66 | 0.060 |
Why?
|
| Microdissection | 1 | 2005 | 18 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2006 | 154 | 0.060 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 1 | 2005 | 3 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 590 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 1431 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 164 | 0.060 |
Why?
|
| Cryotherapy | 1 | 2005 | 30 | 0.060 |
Why?
|
| Clone Cells | 1 | 2005 | 223 | 0.060 |
Why?
|
| Indoles | 1 | 2007 | 317 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2005 | 88 | 0.060 |
Why?
|
| Virus Shedding | 1 | 2005 | 29 | 0.060 |
Why?
|
| Eosinophilia | 1 | 2005 | 89 | 0.060 |
Why?
|
| Neurons, Afferent | 2 | 2003 | 78 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 713 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 249 | 0.060 |
Why?
|
| Mast Cells | 1 | 2005 | 97 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2020 | 1010 | 0.060 |
Why?
|
| Esophagus | 1 | 2005 | 111 | 0.060 |
Why?
|
| Trypsin | 1 | 2004 | 95 | 0.050 |
Why?
|
| Ribavirin | 1 | 2004 | 40 | 0.050 |
Why?
|
| Injections | 2 | 2020 | 126 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2005 | 692 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 377 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2005 | 1267 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 1323 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 444 | 0.050 |
Why?
|
| Phenotype | 2 | 2008 | 2579 | 0.050 |
Why?
|
| Cell Line | 1 | 2008 | 2533 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 262 | 0.050 |
Why?
|
| Appendicitis | 1 | 2004 | 66 | 0.050 |
Why?
|
| Rats | 6 | 2007 | 4154 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2005 | 518 | 0.050 |
Why?
|
| Carbazoles | 1 | 2003 | 31 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 220 | 0.050 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2003 | 19 | 0.050 |
Why?
|
| Phyllodes Tumor | 1 | 2003 | 8 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 701 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2009 | 938 | 0.050 |
Why?
|
| Breast Neoplasms, Male | 1 | 2003 | 31 | 0.050 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2003 | 35 | 0.050 |
Why?
|
| Biphenyl Compounds | 1 | 2003 | 62 | 0.050 |
Why?
|
| Cell Survival | 1 | 2005 | 1032 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2005 | 235 | 0.050 |
Why?
|
| Chicago | 2 | 2020 | 1503 | 0.050 |
Why?
|
| Stents | 1 | 2006 | 425 | 0.050 |
Why?
|
| Kinetics | 1 | 2005 | 1562 | 0.050 |
Why?
|
| Hodgkin Disease | 1 | 2004 | 170 | 0.050 |
Why?
|
| Cyclophosphamide | 3 | 2008 | 313 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2005 | 266 | 0.050 |
Why?
|
| Immunocompromised Host | 3 | 2008 | 147 | 0.050 |
Why?
|
| Alanine Transaminase | 3 | 2007 | 73 | 0.050 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2002 | 6 | 0.050 |
Why?
|
| Dirofilariasis | 1 | 2002 | 2 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2005 | 394 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 473 | 0.050 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2002 | 26 | 0.050 |
Why?
|
| Receptors, Thrombin | 1 | 2001 | 3 | 0.050 |
Why?
|
| Cystadenoma, Serous | 1 | 2001 | 16 | 0.050 |
Why?
|
| Cystadenoma, Papillary | 1 | 2001 | 9 | 0.050 |
Why?
|
| Heart | 1 | 2005 | 592 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2003 | 233 | 0.040 |
Why?
|
| Prognosis | 2 | 2020 | 4033 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3927 | 0.040 |
Why?
|
| Hematocrit | 1 | 2001 | 69 | 0.040 |
Why?
|
| Kupffer Cells | 1 | 2001 | 14 | 0.040 |
Why?
|
| Equipment Design | 3 | 2007 | 427 | 0.040 |
Why?
|
| Klebsiella | 1 | 2001 | 6 | 0.040 |
Why?
|
| Brain | 3 | 2007 | 2482 | 0.040 |
Why?
|
| Gastroscopy | 1 | 2001 | 25 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2001 | 395 | 0.040 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2002 | 139 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2001 | 326 | 0.040 |
Why?
|
| Physical Stimulation | 3 | 2005 | 76 | 0.040 |
Why?
|
| Nasal Cavity | 1 | 2001 | 94 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 657 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2001 | 304 | 0.040 |
Why?
|
| Genotype | 2 | 2020 | 1882 | 0.040 |
Why?
|
| Epididymis | 1 | 2000 | 19 | 0.040 |
Why?
|
| Biomarkers | 2 | 2006 | 1933 | 0.040 |
Why?
|
| Models, Animal | 3 | 2007 | 288 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 3490 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 128 | 0.040 |
Why?
|
| International Cooperation | 1 | 2020 | 134 | 0.040 |
Why?
|
| Adenomatous Polyps | 1 | 2019 | 15 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2013 | 340 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 3 | 2005 | 40 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 1534 | 0.040 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 135 | 0.040 |
Why?
|
| Methylene Blue | 1 | 2019 | 18 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1054 | 0.040 |
Why?
|
| Interleukin-16 | 1 | 2019 | 7 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 2019 | 63 | 0.040 |
Why?
|
| Indocyanine Green | 1 | 2019 | 25 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2002 | 235 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2019 | 42 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2000 | 272 | 0.040 |
Why?
|
| Viral Envelope Proteins | 3 | 2005 | 95 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 62 | 0.040 |
Why?
|
| Ultrasonography, Mammary | 1 | 2019 | 84 | 0.040 |
Why?
|
| Carcinoma, Lobular | 1 | 2019 | 85 | 0.040 |
Why?
|
| Pain Measurement | 3 | 2005 | 378 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 81 | 0.030 |
Why?
|
| Response Evaluation Criteria in Solid Tumors | 1 | 2018 | 60 | 0.030 |
Why?
|
| Time Factors | 4 | 2008 | 5585 | 0.030 |
Why?
|
| Risk Factors | 1 | 2008 | 5960 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2019 | 166 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 354 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2018 | 100 | 0.030 |
Why?
|
| Reference Values | 1 | 2019 | 675 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 930 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2000 | 623 | 0.030 |
Why?
|
| Viral Load | 2 | 2009 | 164 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 514 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 2059 | 0.030 |
Why?
|
| Survival Rate | 1 | 2001 | 1986 | 0.030 |
Why?
|
| Dogs | 2 | 2009 | 719 | 0.030 |
Why?
|
| Blood Cells | 2 | 2006 | 34 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2017 | 129 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 194 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 404 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1011 | 0.030 |
Why?
|
| Blood Chemical Analysis | 2 | 2006 | 41 | 0.030 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2018 | 188 | 0.030 |
Why?
|
| Disease Progression | 1 | 2001 | 1568 | 0.030 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2016 | 16 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1958 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2005 | 16 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 328 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1195 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 133 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2018 | 513 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2006 | 2591 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2019 | 3586 | 0.030 |
Why?
|
| Splenectomy | 1 | 2014 | 82 | 0.030 |
Why?
|
| Amylases | 2 | 2005 | 14 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 323 | 0.030 |
Why?
|
| Substance P | 2 | 2005 | 62 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 539 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2014 | 109 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2163 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2013 | 70 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 89 | 0.030 |
Why?
|
| Saponins | 1 | 2013 | 41 | 0.030 |
Why?
|
| Azoxymethane | 1 | 2013 | 84 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2014 | 168 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 100 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2005 | 2092 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2004 | 67 | 0.020 |
Why?
|
| United States | 2 | 2020 | 7767 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 141 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2013 | 294 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2008 | 995 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1761 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 206 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2011 | 86 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2011 | 237 | 0.020 |
Why?
|
| Fats | 1 | 2010 | 12 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2011 | 172 | 0.020 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2011 | 156 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 3107 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2010 | 72 | 0.020 |
Why?
|
| Brazil | 1 | 2010 | 82 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 132 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2009 | 26 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 438 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 42 | 0.020 |
Why?
|
| Weaning | 1 | 2008 | 26 | 0.020 |
Why?
|
| Encephalitis Virus, Eastern Equine | 1 | 2008 | 1 | 0.020 |
Why?
|
| Sindbis Virus | 1 | 2008 | 4 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2422 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 2008 | 57 | 0.020 |
Why?
|
| Aedes | 1 | 2008 | 13 | 0.020 |
Why?
|
| Arthritis, Infectious | 1 | 2008 | 18 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 297 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 935 | 0.020 |
Why?
|
| Isoindoles | 1 | 2007 | 15 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2007 | 34 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2008 | 535 | 0.020 |
Why?
|
| Carrier State | 1 | 2007 | 40 | 0.020 |
Why?
|
| Rupture | 1 | 2006 | 62 | 0.020 |
Why?
|
| Lassa Fever | 1 | 2006 | 4 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2006 | 27 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 1 | 2006 | 17 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 2006 | 15 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2007 | 309 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2007 | 90 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 138 | 0.020 |
Why?
|
| Point Mutation | 1 | 2007 | 247 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2007 | 206 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2006 | 90 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 201 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2005 | 18 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 2014 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 873 | 0.010 |
Why?
|
| Video Recording | 1 | 2006 | 214 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 192 | 0.010 |
Why?
|
| Paper | 1 | 2005 | 12 | 0.010 |
Why?
|
| Culex | 1 | 2005 | 1 | 0.010 |
Why?
|
| Serum | 1 | 2005 | 25 | 0.010 |
Why?
|
| Lasers | 1 | 2005 | 102 | 0.010 |
Why?
|
| Prednisone | 1 | 2005 | 258 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 813 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 297 | 0.010 |
Why?
|
| TRPV Cation Channels | 1 | 2004 | 16 | 0.010 |
Why?
|
| Hindlimb | 1 | 2005 | 97 | 0.010 |
Why?
|
| Cadaver | 1 | 2005 | 204 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 2004 | 54 | 0.010 |
Why?
|
| Diarrhea | 1 | 2005 | 181 | 0.010 |
Why?
|
| Abdomen | 1 | 2005 | 127 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2005 | 397 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2005 | 274 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 175 | 0.010 |
Why?
|
| Nausea | 1 | 2005 | 182 | 0.010 |
Why?
|
| Schools | 1 | 2004 | 84 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 358 | 0.010 |
Why?
|
| Vomiting | 1 | 2005 | 201 | 0.010 |
Why?
|
| Indole Alkaloids | 1 | 2003 | 3 | 0.010 |
Why?
|
| Laparotomy | 1 | 2004 | 69 | 0.010 |
Why?
|
| Receptor, trkA | 1 | 2003 | 14 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 197 | 0.010 |
Why?
|
| Tachykinins | 1 | 2003 | 13 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 766 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1666 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 426 | 0.010 |
Why?
|
| Peroxidase | 1 | 2003 | 54 | 0.010 |
Why?
|
| Pain Threshold | 1 | 2003 | 63 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2005 | 369 | 0.010 |
Why?
|
| Edema | 1 | 2003 | 73 | 0.010 |
Why?
|
| Burns | 1 | 2005 | 150 | 0.010 |
Why?
|
| West Nile Virus Vaccines | 1 | 2002 | 1 | 0.010 |
Why?
|
| Arginine | 1 | 2003 | 144 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 112 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2003 | 138 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 2002 | 75 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2005 | 418 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 615 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 267 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 283 | 0.010 |
Why?
|
| Endocytosis | 1 | 2003 | 186 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2004 | 294 | 0.010 |
Why?
|
| Posterior Horn Cells | 1 | 2001 | 9 | 0.010 |
Why?
|
| Drug Administration Routes | 1 | 2001 | 21 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2003 | 252 | 0.010 |
Why?
|
| Capsaicin | 1 | 2001 | 45 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 2001 | 88 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2002 | 90 | 0.010 |
Why?
|
| Transgenes | 1 | 2002 | 186 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 372 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2005 | 710 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 741 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 1157 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 705 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 935 | 0.010 |
Why?
|
| Contrast Media | 1 | 2003 | 1096 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 1645 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2943 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 1815 | 0.010 |
Why?
|